EBM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Puntis, J. W L
Right arrow Search for Related Content
PubMed
Right arrow Articles by Puntis, J. W L
Evidence-Based Medicine 2004; 9:179
© 2004 BMJ Publishing Group Ltd.


Therapeutics

Review: rotavirus vaccines moderately reduce rotavirus diarrhoea in children

Soares-Weiser K, Goldberg E, Tamimi G, et al. Rotavirus vaccine for preventing diarrhoea. Cochrane Database Syst Rev 2004;(1):CD002848.

Q In children and adults, are rotavirus vaccines effective for preventing rotavirus diarrhoea?

Clinical impact ratings Paediatrics ******{star} Tropical medicine *****{star}{star} Infectious disease ****{star}{star}{star}

Key Words: diarrhoea • rotavirus infections • rotavirus vaccines

The first 150 words of the full text of this article appear below.

METHODS
{ebmcmptrbooks.f1}Data sources: Cochrane Infectious Diseases Group’s trials register, Medline, EMBASE/Excerpta Medica, LILACS, Biological Abstracts (all up to October 2003), Cochrane Central Register of Controlled Trials (2003, Issue 3), bibliographies of relevant articles, and contact with researchers and a rotavirus manufacturer (Merck Sharp & Dohme).

{ebmmgnfyglas.f1}Study selection and assessment: randomised controlled trials (RCTs) in any language that compared rotavirus vaccines with placebo, no vaccination, or a different rotavirus vaccine in children or adults. Study quality was assessed for method of allocation, allocation concealment, blinding, sample size, exclusions after randomisation, and follow up period.

{ebmruler.f1}Outcomes: rotavirus diarrhoea, all cause diarrhoea, all cause mortality, and adverse events.

MAIN RESULTS
63 RCTs of children (age range newborns to 12 years) and 1 small safety study of 10 adults (21–30 years of age) met the selection criteria. Main types of vaccines evaluated included bovine (13 RCTs), human (2 RCTs), rhesus (32 RCTs), and the combined bovine and . . . [Full text of this article]

John W L Puntis, BM (Hons), DM, FRCP, FRCPCH

The General Infirmary at Leeds, University of Leeds
Leeds, UK







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 by the BMJ Publishing Group Ltd.